327 related articles for article (PubMed ID: 24555622)
21. Diffusion tensor imaging in the differentiation of adrenal adenomas and metastases.
Işık Y; Gürses B; Taşdelen N; Kılıçkesmez O; Fırat Z; Ordu C; Gürmen N
Diagn Interv Radiol; 2012; 18(2):189-94. PubMed ID: 21960162
[TBL] [Abstract][Full Text] [Related]
22. Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension.
Rosenkrantz AB; Chandarana H; Gilet A; Deng FM; Babb JS; Melamed J; Taneja SS
J Magn Reson Imaging; 2013 Aug; 38(2):312-9. PubMed ID: 23238968
[TBL] [Abstract][Full Text] [Related]
23. Diffusion kurtosis imaging study of prostate cancer: preliminary findings.
Tamura C; Shinmoto H; Soga S; Okamura T; Sato H; Okuaki T; Pang Y; Kosuda S; Kaji T
J Magn Reson Imaging; 2014 Sep; 40(3):723-9. PubMed ID: 24924835
[TBL] [Abstract][Full Text] [Related]
24. Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade.
Takeuchi M; Sasaki S; Ito M; Okada S; Takahashi S; Kawai T; Suzuki K; Oshima H; Hara M; Shibamoto Y
Radiology; 2009 Apr; 251(1):112-21. PubMed ID: 19332849
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic evaluation of diffusion kurtosis imaging for prostate cancer: Detection in a biopsy population.
Ding K; Yao Y; Gao Y; Lu X; Chen H; Tang Q; Hua C; Zhou M; Zou X; Yin Q
Eur J Radiol; 2019 Sep; 118():138-146. PubMed ID: 31439233
[TBL] [Abstract][Full Text] [Related]
26. Diffusion tensor MRI: preliminary anisotropy measures and mapping of breast tumors.
Partridge SC; Ziadloo A; Murthy R; White SW; Peacock S; Eby PR; DeMartini WB; Lehman CD
J Magn Reson Imaging; 2010 Feb; 31(2):339-47. PubMed ID: 20099346
[TBL] [Abstract][Full Text] [Related]
27. Role of apparent diffusion coefficient values and diffusion-weighted magnetic resonance imaging in differentiation between benign and malignant thyroid nodules.
Mutlu H; Sivrioglu AK; Sonmez G; Velioglu M; Sildiroglu HO; Basekim CC; Kizilkaya E
Clin Imaging; 2012; 36(1):1-7. PubMed ID: 22226435
[TBL] [Abstract][Full Text] [Related]
28. Value of diffusion-weighted imaging at 3 T for prediction of extracapsular extension in patients with prostate cancer: a preliminary study.
Chong Y; Kim CK; Park SY; Park BK; Kwon GY; Park JJ
AJR Am J Roentgenol; 2014 Apr; 202(4):772-7. PubMed ID: 24660705
[TBL] [Abstract][Full Text] [Related]
29. Anterior Prostate Cancer: Diagnostic Performance of T2-Weighted MRI and an Apparent Diffusion Coefficient Map.
Shinmoto H; Tamura C; Soga S; Okamura T; Horiguchi A; Asano T; Kaji T
AJR Am J Roentgenol; 2015 Aug; 205(2):W185-92. PubMed ID: 26204306
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of a logistic regression model to distinguish transition zone cancers from benign prostatic hyperplasia on multi-parametric prostate MRI.
Iyama Y; Nakaura T; Katahira K; Iyama A; Nagayama Y; Oda S; Utsunomiya D; Yamashita Y
Eur Radiol; 2017 Sep; 27(9):3600-3608. PubMed ID: 28289941
[TBL] [Abstract][Full Text] [Related]
31. Diffusion-weighted imaging of prostate cancer using a statistical model based on the gamma distribution.
Shinmoto H; Oshio K; Tamura C; Soga S; Okamura T; Yamada K; Kaji T; Mulkern RV
J Magn Reson Imaging; 2015 Jul; 42(1):56-62. PubMed ID: 25223894
[TBL] [Abstract][Full Text] [Related]
32. Diffusion-weighted MRI as a predictor of extracapsular extension in prostate cancer.
Kim CK; Park SY; Park JJ; Park BK
AJR Am J Roentgenol; 2014 Mar; 202(3):W270-6. PubMed ID: 24555624
[TBL] [Abstract][Full Text] [Related]
33. Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer.
Rosenkrantz AB; Sigmund EE; Johnson G; Babb JS; Mussi TC; Melamed J; Taneja SS; Lee VS; Jensen JH
Radiology; 2012 Jul; 264(1):126-35. PubMed ID: 22550312
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging.
Oto A; Kayhan A; Jiang Y; Tretiakova M; Yang C; Antic T; Dahi F; Shalhav AL; Karczmar G; Stadler WM
Radiology; 2010 Dec; 257(3):715-23. PubMed ID: 20843992
[TBL] [Abstract][Full Text] [Related]
35. Diffusion-weighted imaging of the prostate: Comparison of b1000 and b2000 image sets for index lesion detection.
Rosenkrantz AB; Hindman N; Lim RP; Das K; Babb JS; Mussi TC; Taneja SS
J Magn Reson Imaging; 2013 Sep; 38(3):694-700. PubMed ID: 23371846
[TBL] [Abstract][Full Text] [Related]
36. Non-Gaussian water diffusion kurtosis imaging of prostate cancer.
Suo S; Chen X; Wu L; Zhang X; Yao Q; Fan Y; Wang H; Xu J
Magn Reson Imaging; 2014 Jun; 32(5):421-7. PubMed ID: 24602826
[TBL] [Abstract][Full Text] [Related]
37. [Diffusion weighted imaging: its diagnostic and differential value for prostate cancer].
Shi H; Ding HY
Zhonghua Nan Ke Xue; 2007 Jul; 13(7):605-9. PubMed ID: 17725302
[TBL] [Abstract][Full Text] [Related]
38. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2.
Kim CK; Park BK; Kim B
AJR Am J Roentgenol; 2010 Jan; 194(1):W33-7. PubMed ID: 20028888
[TBL] [Abstract][Full Text] [Related]
39. Clinical utility of apparent diffusion coefficient values obtained using high b-value when diagnosing prostate cancer using 3 tesla MRI: comparison between ultra-high b-value (2000 s/mm²) and standard high b-value (1000 s/mm²).
Kitajima K; Takahashi S; Ueno Y; Yoshikawa T; Ohno Y; Obara M; Miyake H; Fujisawa M; Sugimura K
J Magn Reson Imaging; 2012 Jul; 36(1):198-205. PubMed ID: 22371381
[TBL] [Abstract][Full Text] [Related]
40. Correlation of magnetic resonance diffusion tensor imaging and clinical findings of cervical myelopathy.
Yoo WK; Kim TH; Hai DM; Sundaram S; Yang YM; Park MS; Kim YC; Kwak YH; Ohn SH; Kim SW
Spine J; 2013 Aug; 13(8):867-76. PubMed ID: 23523441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
